Previous close | 51.27 |
Open | 51.08 |
Bid | 49.83 x 800 |
Ask | 52.82 x 800 |
Day's range | 51.05 - 51.99 |
52-week range | 43.39 - 62.88 |
Volume | |
Avg. volume | 1,044,946 |
Market cap | 6.964B |
Beta (5Y monthly) | 1.10 |
PE ratio (TTM) | 48.07 |
EPS (TTM) | 1.07 |
Earnings date | 02 May 2024 - 06 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 61.46 |
GMED vs. PEN: Which Stock Is the Better Value Option?
AUDUBON, Pa., April 16, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, 2024 after the market close on Tuesday, May 7, 2024. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com. Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4:30 p.m.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.